Pancreatic adenocarcinoma Trials in Chicago, United States
Conditions / Pancreatic adenocarcinoma / Chicago, United States
Pancreatic adenocarcinoma is a medical condition with active clinical research programs worldwide.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02562716 | S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery | COMPLETED | PHASE2 |
| NCT05365581 | A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer | RECRUITING | — |
| NCT05245500 | Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion | RECRUITING | PHASE1 |
| NCT06778863 | A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation | RECRUITING | PHASE1 |
| NCT01013649 | Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery | COMPLETED | PHASE3 |
| NCT06115499 | The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3 |
| NCT02376699 | Safety Study of SEA-CD40 in Cancer Patients | TERMINATED | PHASE1 |
| NCT02839343 | Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer | UNKNOWN | PHASE2 |
| NCT03678883 | 9-ING-41 in Patients with Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT02586987 | A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours | COMPLETED | PHASE1 |